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Background: Streptococcus pneumonia (SP) is themost common
nfectious cause of nondiarrheal hemolytic uremic syndrome (HUS)
eﬁned as microangiopathic hemolytic anemia, thrombocytopenia
nd renal failure with absence of diarrheal infection from Shiga-
oxin expressing Escherichia coli (STEC). S. pneumoniae-associated
emolytic uremic syndrome (SP-HUS) usually presents as severe
nfection with complicated pneumonia and empyema. SP-HUS has
ore morbidity and mortality than other forms of invasive pneu-
ococcal diseases (IPD).
Methods: We present a case of a-2-year-old Thai girl with
P-HUS characterized by severe pneumonia with empyema,
icroangiopathic hemolytic anemia, thrombocytopenia and renal
ailure.
Results: The patient presented with high fever and dysp-
ea for 4 days. Physical examinations revealed ﬁne crepitation
nd decreased breath sound of left lower lung with oxygen
esaturation. Chest x-ray and ultrasonography of chest showed
obar consolidation with loculated pleural effusion of left lower
ung. Hemoculture yielded S. pneumonia which identiﬁed later
s serotype 19A. MIC for ceftriaxone was 2 mcg/mL and MIC
or penicillin was more than 2 mcg/mL. Isolate remained sus-
eptible to vancomycin and levoﬂoxacin. The patient received
igh dose vancomycin with ceftriaxone. However, she still have
ersisted fever, upper gastrointestinal bleeding with microangio-
athic hemolytic anemia, thrombocytopenia and renal failure. She
eveloped empyema thoracis of left lung which was done thora-
otomy decortication. Finding showed loculated debris with pus.
he responded well with antibiotics, ﬂuid restriction, diuretics and
an be discharged home eventually. The patient has never received
neumococcal conjugate vaccine so she received 13-valent pneu-
ococcal conjugate vaccine (PCV13) at followed-up visit.
Conclusion: SP-HUS has severe clinical manifestations and
igniﬁcant morbidity. Serotype 19A is detected as predominant
mergence serotypeand is also included inPCV13.Vaccinationwith
CV13 has potential to decrease the incidence of IPD and SP-HUS.
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Background: Acute respiratory infection (ARI) is common in
youngchildrenand inﬂuenzavirusesandrespiratory syncytial virus
(RSV) are the leading pathogens. Childrenwith underlying diseases
are at increased risk of severe ARI-associated illness compared to
healthy children, but it is not known if they are at increased risk
of developing ARIs. Quantifying risk will help guide decisions on
prioritizing national prevention programs including vaccination.
Methods: We initiated a 2-year longitudinal study at Queen
Sirikit National Institute of Child Health (QSNICH) in Bangkok. We
prospectively enrolled children aged 0-36 months with underly-
ing disease (e.g., preterm, cardiopulmonary, neurological disease)
as exposed and age- and time at enrollment-matched healthy chil-
dren as unexposed. An episode of ARI was deﬁned as ≥2 of the
following: fever, cough, sore throat or rhinorrhea. Children seeking
care at QSNICH had a nasal swab tested for inﬂuenza viruses and
RSV by RT-PCR.
Results: Between 3 Aug-27 Nov 2011, 91 exposed (mean
age 14.8 months) and 126 unexposed children (mean age 14.3
months) were enrolled. Exposed children reported 62 (68%) new
ARI episodes compared to 67 (53%) of the unexposed (p=0.03);
there was no difference in the proportion seeking care (53/62, 86%
vs.55/67, 82%, p =0.60). Incidence of medically attended ARI was
57.9 and 41.8 per 1000 child weeks in exposed and unexposed
children, respectively. Among those seeking care, hospitalization
was signiﬁcantly more likely in exposed compared to unexposed
children (11/53, 21% versus 3/55, 5.5%, p =0.02); median length
of stay was longer but not signiﬁcantly (10 vs. 3 days, p =0.24).
Inﬂuenza and RSV were less frequent in exposed children (1/31,
3% and 7/31, 23%) compared to unexposed children (5/42, 12% and
14/42, 33%), but not signiﬁcantly. Of 21 RSV-conﬁrmed ARI, 3/7
(43%) exposed children had illness duration >15 days compared to
1/14 (7.1%) unexposed (p=0.09). One (14%) exposed childwith RSV
was hospitalized compared to none of the unexposed (p=0.33).
Conclusion: The results suggest that children with co-
morbidities have signiﬁcantly higher risk of ARI and of subsequent
hospitalization compared to healthy children. In RSV-conﬁrmed
ARIs, children with an underlying disease tended to have longer
illness duration and more severe disease.
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